Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality
Circulation: Heart Failure · 2024-09 · 17 (9)
DOI: 10.1161/circheartfailure.124.011827 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Heart Failure, 2024-09. Verfasst von Miguel A Chavez und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City (M.A.C., M.A., C.P.K., M.…. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Vasodilation, Vascular Resistance. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Cardiogenic shock (CS) mortality remains near 40%. In addition to inadequate cardiac output, patients with severe CS may exhibit vasodilation. We aimed to examine the prevalence and consequences of vasodilation in CS. METHODS: We analyzed all patients hospitalized at a CS referral center who were diagnosed with CS stages B to E and did not have concurrent sepsis or recent cardiac surgery. Vasodilation was defined by lower systemic vascular resistance (SVR), higher norepinephrine equivalent dose, or a blunted SVR response to pressors. Threshold SVR values were determined by their relation to 14-day mortality in spline models. The primary outcome was death within 14 days of CS onset in multivariable-adjusted Cox models. RESULTS: This study included 713 patients with a mean age of 60 years and 27% females; 14-day mortality was 28%, and 38% were vasodilated. The median SVR was 1308 dynes•s•cm −5 (interquartile range, 870–1652), median norepinephrine equivalent was 0.11 µg/kg per minute (interquartile range, 0–0.2), and 28% had a blunted pressor response. Each 100-dynes•s•cm −5 decrease in SVR below 800 was associated with 20% higher mortality (adjusted hazard ratio, 1.23; P =0.004). Each 0.1-µg/kg per minute increase in norepinephrine equivalent dose was associated with 15% higher mortality (adjusted hazard ratio, 1.12; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City (M.A.C., M.A., C.P.K., M.S., E.D., I.T., J.L., B.K., J.G., M.G., C.H.S., J.E.T., J.C.F., S.G.D.…
- Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City (E.M., R.H., S.G.D.).
- Division of Cardiology, Department of Medicine, University of California, San Diego, La Jolla (I.T.).
- Peter Munk Cardiac Centre, University of Toronto, ON, Canada (F.B.).
- Department of Cardiovascular Medicine, Cleveland Clinic Heart, Vascular, and Thoracic Institute, Weston, FL (D.A.B.).
- Inova Fairfax Hospital, Falls Church, VA (B.T.).
ORCID-Profile: McHale Anderson, Christos P Kyriakopoulos, Monte Scott, Elizabeth Dranow, Eleni Maneta, Rana Hamouche, Iosif Taleb, Benjamin Kogelschatz, Filio Billia, Matt Goodwin, Craig H Selzman, Joseph E Tonna, James C Fang, Stavros G Drakos
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Chavez, M. A., Anderson, M., Kyriakopoulos, C. P., Scott, M., Dranow, E., Maneta, E., Hamouche, R., Taleb, I., Leon, J., Kogelschatz, B., Goldstein, J., Billia, F., Baran, D. A., Tehrani, B., Goodwin, M., Selzman, C. H., Tonna, J. E., Fang, J. C., Drakos, S. G., & Hanff, T. C. (2024). Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality. Circulation: Heart Failure, 17(9). https://doi.org/10.1161/circheartfailure.124.011827
Vancouver
Chavez MA, Anderson M, Kyriakopoulos CP, Scott M, Dranow E, Maneta E, et al. Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality. Circulation: Heart Failure. 2024;17(9). doi:10.1161/circheartfailure.124.011827
BibTeX
@article{Chavez2024,
author = {Chavez, Miguel A and Anderson, McHale and Kyriakopoulos, Christos P and Scott, Monte and Dranow, Elizabeth and Maneta, Eleni and Hamouche, Rana and Taleb, Iosif and Leon, Jacy and Kogelschatz, Benjamin and Goldstein, Jake and Billia, Filio and Baran, David A and Tehrani, Behnam and Goodwin, Matt and Selzman, Craig H and Tonna, Joseph E and Fang, James C and Drakos, Stavros G and Hanff, Thomas C},
title = {Pathophysiologic Vasodilation in Cardiogenic Shock and Its Impact on Mortality},
journal = {Circulation: Heart Failure},
year = {2024},
volume = {17},
number = {9},
doi = {10.1161/circheartfailure.124.011827}
}
EUVIMED